Biolargo Inc

Greetings. Welcome to the BioLargo second quarter 2024 earnings results conference call. At this time, all participants are in a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now hand the conference over to your host, Brian Loper. You may begin.

Great. Thank you, Holly. Appreciate that. Good afternoon, everyone. Good afternoon, everyone. Welcome to BioLargo's Q2 2024 earnings results conference call for the month ended June 30th, 2024. By now, everyone should have had access to the earnings press release, which was issued on August 6th. This call is being webcast and is available for replay. In our remarks today, we will include statements that are considered forward-looking within the meanings of securities laws, including forward-looking statements about future results of operations, business strategies and plans, our relationships with our customers, market, and potential growth opportunities. In addition, management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current knowledge and expectations as of today and are subject to certain risks and uncertainties and may cause the actual results to differ materially from the forward-looking statement. A detailed discussion of such risks and uncertainties is contained in our most recent form, 10-K, 10-Q, and other reports filed at the SEC. The company undertakes no obligation to update any forward-looking statements. And with that, I will now hand the call over to Biologos Chief Executive Officer, Dennis Calvert.

Hey, Brian. Thank you very much, and thank you, everyone, for joining us. I also want to mention Charles Dargan is with us, our CFO. Charlie, say hi. Are you there?